Related Experiment Video
Updated: Apr 5, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Maternal Asthma, Preterm Birth, and Risk of Bronchopulmonary Dysplasia
Susan Gage1, Peiyi Kan1, Henry C Lee2
1Department of Pediatrics, Stanford University, Stanford, CA.
Insights
Maternal asthma increases preterm birth risk. However, bronchopulmonary dysplasia (BPD) risk in preterm infants is only elevated if mothers with asthma do not receive antenatal steroids.
Area of Science:
- Neonatal Health
- Perinatal Medicine
- Respiratory Medicine
Background:
- Maternal asthma is a common comorbidity during pregnancy.
- Bronchopulmonary dysplasia (BPD) is a significant complication in preterm infants.
- The impact of maternal asthma on BPD development requires further investigation.
Purpose of the Study:
- To examine the association between maternal asthma and the risk of bronchopulmonary dysplasia (BPD) in preterm infants.
- To investigate if maternal asthma influences preterm birth subtypes.
- To determine the role of antenatal steroid treatment in mitigating BPD risk in infants of mothers with asthma.
Main Methods:
- Utilized a large California population-based cohort (2007-2010) of over 2 million pregnancies.
- Analyzed maternal delivery discharge records and International Classification of Diseases, Ninth Revision codes.
- Linked datasets to identify 21,944 singleton preterm infants and their mothers' asthma status.
Main Results:
- Maternal asthma was linked to a 42% increased odds of preterm birth (<37 weeks gestational age).
- No overall elevated risk of BPD was observed in preterm infants born to mothers with asthma.
- Infants of mothers with asthma who did not receive antenatal steroids had a 54% increased odds of BPD.
Conclusions:
- Maternal asthma is associated with an increased risk of preterm birth.
- Antenatal steroid treatment appears to negate the increased BPD risk in infants born to mothers with asthma.
- Targeted antenatal interventions may be crucial for managing BPD risk in this population.
Objective:
To study the relationship between maternal asthma and the development of bronchopulmonary dysplasia (BPD).
Study Design:
Using a large population-based California cohort, we investigated associations between maternal asthma and preterm birth subtype, as well as maternal asthma and BPD. We used data from 2007-2010 maternal delivery discharge records of 2 009 511 pregnancies and International Classification of Diseases, Ninth Revision codes. Preterm birth was defined as <37 weeks gestational age (GA), with subgroups of <28 weeks, 28-32 weeks, and 33-37 weeks GA, as well as preterm subtype, defined as spontaneous, medically indicated, or unknown. Linkage between the 2 California-wide datasets yielded 21 944 singleton preterm infants linked to their mother's records, allowing estimation of the risk of BPD in mothers with asthma and those without asthma.
Results:
Maternal asthma was associated with increased odds (OR, 1.42; 95% CI, 1.38-1.46) of preterm birth at <37 weeks GA, with the greatest risk for 28-32 GA (aOR, 1.60; 95% CI, 1.47-1.74). Among 21 944 preterm infants, we did not observe an elevated risk for BPD in infants born to mothers with asthma (aOR, 1.03; 95% CI, 0.9-1.2). Stratification by maternal treatment with antenatal steroids revealed increased odds of BPD in infants whose mothers had asthma but did not receive antenatal steroids (aOR, 1.54; 95% CI, 1.15-2.06), but not in infants whose mothers had asthma and were treated with antenatal steroids (aOR, 0.85; 95% CI, 0.67-1.07).
Conclusion:
Asthma in mothers who did not receive antenatal steroid treatment is associated with an increased risk of BPD in their preterm infants.
Related Concept Videos
Breathing
Asthma-I: Introduction
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Development of the Oral Microbiota
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Pulmonary Cycle: Exhalation

